Cutera, Inc.

Cutera, Inc.

Cutera, Inc.

Overview
Date Founded

1998

Headquarters

3240 BAYSHORE BOULEVARD, BRISBANE, CA, 94005

Type of Company

Public

Employees (Worldwide)

402

Industries

Medical Products & Equipment
Hospitals & Patient Services

Company Description

Cutera, Inc. provides laser and energy-based aesthetic systems for practitioners, which engages in the design, development, manufacture, marketing and servicing of laser and other energy based aesthetics systems for practitioners. Its products include Enlighten, TruSculpt, Excel HR, Excel V, and Xeo. The company was founded by David A. Gollnick in August 1998 and is headquartered in Brisbane, CA.

Contact Data
Trying to get in touch with decision makers at Cutera, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer & Director

President

Chief Financial Officer

Vice President, General Counsel & Corporate Secretary

Executive Vice President, Chief Technology Officer

Executive Vice President, Sales, North America

Senior Vice President, Global Marketing & Clinical Development

Vice President, Finance

Vice President, Manufacturing & Service

Vice President, Research & Development

Board of Directors

Founder at Voce Capital Management LLC

President at Natural Products Group, Inc.

Executive Partner, Growth Buyout Team at Frazier Healthcare Partners

Chief Executive Officer & Director at Cutera, Inc.

Former Corporate Vice President-Business Development at Boston Scientific Corporation

President at American Society for Laser Medicine & Surgery

Former President & Chief Executive Officer at DFine, Inc.

President at Cutera, Inc.

Former Chief Executive Officer at Arbonne International LLC

Paths to Cutera, Inc.
Potential Connections via
Relationship Science
You
Cutera, Inc.
Owners & Shareholders
Details Hidden

Paradigm Capital Management's (PCM) investment approach is based on the belief that the equity markets are inefficient and that investor psychology and sentiment have a significant impact on short-term pricing. The firm believes that extensive academic research supports the firm's opinion that these phenomena are especially prevalent in the smaller end of the market capitalization spectrum. PCM conducts disciplined fundamental research to identify mispriced small-cap equities whose short-term pricing does not accurately reflect the true earning potential of the company. PCM looks for what they feel are high-quality companies that are trading at discounts to their assessment of intrinsic value. The firm offers 7 strategies which are primarily offered to clients as investable products: Micro-Cap, Small-Cap, SMid-Cap, Value, Growth & Income, High Net Worth and Defensive.

Details Hidden

Teton Advisors, Inc. (OTC Pink: TETAA) is a multi-strategy investment management company, and is the registered investment adviser to six open-end mutual funds under the TETON Westwood brand. We offer our funds and separately managed accounts to individuals and institutions directly and through third party intermediaries. An affiliate of GAMCO Investors, Inc. (NYSE: GBL), Teton Advisors, Inc. shares the fundamental, research-driven investment philosophy of GAMCO Investors, Inc.

Details Hidden

Voce Capital Management (VCM) focuses on taking significant, actively managed equity positions in a limited number of publicly-traded US companies they believe are undervalued (or in the case of short investments, overvalued) or whose market valuation does not reflect the company's intrinsic value or true potential. VCM employs primary, proprietary research to identify companies whose current valuation is (or in the case of short investments, is likely to become or should be) impacted by some or all of the following: capital misallocation, managerial deficiencies, operational underperformance, governance dysfunction and/or strategic issues of scale or scope. The firm invests in companies which they believe the catalyst to address such issues is identified and actionable. VCM may attempt to engage in active and substantive dialog with the management, board of directors, advisors and other shareholders of such companies, and the investing public, to effect changes they believe will address the company's issues and narrow the valuation discrepancy. The firm focuses primarily on small-cap companies (generally with $100 million to $4.5 billion in equity market capitalization). VCM is an activist firm and is included in the SharkWatch50 as one the 50 most prominent activist investors.

Recent Transactions
Details Hidden

Cutera, Inc. purchases IRIDEX Corp. /Global Aesthetic Business from Iridex Corp.

Details Hidden

Cutera, Inc. issued Common Stock

Transaction Advisors
Selling Group Member

Advised onCutera, Inc. issued Common Stock

Underwriter

Advised onCutera, Inc. issued Common Stock

Selling Group Member

Advised onCutera, Inc. issued Common Stock

Legal Advisor

Advised onCutera, Inc. issued Common Stock

Legal Advisor

Advised onCutera, Inc. issued Common Stock

Advisors & Consultants
Legal Advisor

Partner at Wilson Sonsini Goodrich & Rosati PC

Legal Advisor

Partner at Wilson Sonsini Goodrich & Rosati PC

Legal Advisor

Partner at Wilson Sonsini Goodrich & Rosati PC

Key Stats and Financials As of 2018
Market Capitalization
$467M
Total Enterprise Value
$199M
Earnings Per Share
$-2.23
Revenue
$163M
Net Profit
$-30.8M
Total Equity
$46.4M
EBITDAMargin
-6.36%
EBITDA
$-10.3M
Enterprise Value Sales
1.22x
Debt TEV
0x
TEVNet Income
-6.46x
Total Debt
$0
Three Year Compounded Annual Growth Rate Of Revenue
19.75%
Five Year Compounded Annual Growth Rate Of Revenue
16.88%
Suppliers
ZO Skin Health, Inc. Hospitals & Patient Services | Irvine, California

ZO Skin Health, Inc. provides skincare solutions. It products include cleanse, scrub, oil control & tone, hydration & calming, sun protection, enhancers and peels. The company was founded by Zein E. Obagi in 2007 and is headquartered in Irvine, CA.

Competitors
Bausch Health Cos., Inc. Pharmaceuticals - Laval, QC

Bausch Health Cos., Inc. engages in the development, manufacture, and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: The Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products. The Bausch + Lomb/International segment consists of the sale of pharmaceutical products, over-the-counter products, and medical devices products. The Branded Rx segment comprises of pharmaceutical products related to the Salix product portfolio; dermatological product portfolio; branded pharmaceutical products, branded generic pharmaceutical products; over-the-counter products; medical device products; Bausch + Lomb products sold in Canada; and the oncology, dentistry, and health products for women. The Salix Segment consists of sales in the U.S. of GI Products, The Ortho Dermatologics segment consists of sales in the U.S. of Ortho Dermatologics (dermatological) products and global sales of Solta medical aesthetic devices. The Diversified Products segment consists of sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, in the U.S. of generic products, in the U.S. of dentistry products. The company was founded on March 29, 1994 and is headquartered in Laval, Canada.

Allergan Plc Pharmaceuticals - Dublin, DU

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

Hologic, Inc. Medical Products & Equipment - MARLBOROUGH, MA

Hologic, Inc. (Nasdaq: HOLX) is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products dedicated to serving the healthcare needs of women throughout the world. At Hologic, we are on a mission: to help women everywhere lead longer, healthier lives. It is our reason for being and the single focus of every breakthrough we pursue, every solution we design, every investment we make. Hologic is a market leader in mammography and breast biopsy, breast magnetic resonance imaging, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia and uterine fibroids, osteoporosis assessment, preterm birth risk assessment, mini C-arm for extremity imaging, and molecular diagnostic products including human papillomavirus (HPV) testing and reagents for a variety of DNA and RNA analysis applications. We are proud of our achievements and conscious of the responsibility that our leadership position brings with it. We believe that the health issues facing women today deserve and demand the singular dedication of a passionate company. Our core business units are focused on breast health, diagnostics, GYN surgical, and skeletal health

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Cutera, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Cutera, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Cutera, Inc..